LGND
Ligand Pharmaceuticals Incorporated
303.00$
+0.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 4.6% | 7.6% | 1.2% | 3.2% | 7.1% | 3.4% | 1.4% | 1.3% | 3.2% | 5.0% | 8.9% | 9.6% | 12.7% | 7.2% | 14.1% | 18.5% | 15.2% | 16.8% | 14.8% | 36.1% | 17.7% | 16.5% | 12.9% | 24.7% | 23.9% | 79.9% | 8.5% | 6.3% | 10.6% | 5.9% | 35.7% | -36.9% | 24.1% | 6.6% | 10.7% | 6.1% | 21.5% | -43.6% | 4.0% | 5.0% | 1.4% | |
| 95.4% | 92.4% | 98.8% | 96.8% | 92.9% | 96.6% | 98.6% | 98.7% | 96.8% | 95.0% | 91.1% | 90.4% | 87.3% | 92.8% | 85.9% | 81.5% | 84.8% | 83.2% | 85.2% | 63.9% | 82.3% | 83.5% | 87.1% | 75.3% | 76.1% | 20.1% | 91.5% | 93.7% | 89.4% | 94.1% | 64.3% | 136.9% | 75.9% | 93.4% | 89.3% | 93.9% | 78.5% | 143.6% | 96.0% | 95.0% | 98.6% | |
| 29.2% | 16.8% | 29.6% | 17.2% | 14.3% | 17.1% | 13.2% | 6.8% | 12.0% | 14.8% | 26.0% | 48.9% | 55.4% | 69.1% | 35.9% | 30.7% | 30.7% | 31.3% | 32.4% | 18.8% | 26.1% | 25.2% | 25.1% | 16.9% | 15.6% | 93.8% | 15.2% | 26.0% | 16.8% | 19.5% | 19.3% | 12.9% | 11.0% | 10.3% | 110.5% | 13.8% | 18.2% | 5.9% | 4.2% | 23.0% | 14.2% | |
| 29.2% | 17.4% | 25.0% | 23.4% | 21.1% | 15.4% | 13.6% | 10.3% | 21.1% | 18.7% | 25.5% | 44.0% | 38.4% | 38.1% | 27.9% | 24.3% | 35.9% | 43.0% | 22.9% | 17.4% | 19.6% | 24.5% | 32.7% | 24.1% | 25.2% | 73.4% | 24.7% | 42.8% | 44.6% | 56.9% | 35.4% | 42.4% | 47.2% | 59.8% | 41.5% | 42.4% | 24.6% | 41.9% | 40.3% | 45.7% | 35.6% | |
| 69.0% | 41.3% | 63.9% | 50.3% | 43.4% | 40.4% | 32.6% | 20.8% | 45.6% | 39.4% | 59.5% | 106.9% | 108.1% | 130.5% | 74.5% | 64.4% | 75.9% | 67.2% | 76.7% | 9.9% | 58.1% | 65.9% | 81.3% | 58.1% | 55.3% | -24.9% | 59.2% | 101.2% | 80.0% | 106.0% | 54.6% | 182.9% | 69.8% | 115.9% | 169.2% | 76.2% | 30.9% | 110.0% | 62.4% | 81.5% | 63.8% | |
| 25.3% | 50.7% | 34.9% | 46.5% | 49.4% | 56.2% | 66.0% | 77.9% | 51.2% | 55.6% | 1,900.8% | -16.5% | -20.8% | -37.7% | 11.4% | 17.1% | 9.0% | 16.0% | 8.5% | 54.0% | 24.2% | 17.6% | 5.8% | 17.3% | 20.8% | 45.0% | 32.3% | -7.5% | 9.4% | -11.9% | 9.6% | -46.0% | 6.1% | -22.5% | -79.9% | 17.7% | 47.6% | 33.6% | 33.6% | 13.5% | 34.7% | |
| 14.4% | 7.9% | 10.0% | 11.9% | 10.1% | 5.5% | 6.2% | 14.9% | 24.5% | 33.8% | 20.5% | 36.1% | 36.3% | 32.7% | 25.8% | 15.0% | 15.0% | 9.1% | 10.6% | 5.8% | 6.8% | 6.2% | 2.2% | 0.9% | 0.6% | 0.9% | 0.5% | 1.1% | 0.0% | 0.5% | 0.5% | 3.1% | 1.4% | 2.1% | 1.9% | 2.4% | 0.8% | 3.0% | 3.4% | 2.7% | 2.1% | |
| 3.7% | 18.9% | 21.2% | 29.6% | 36.2% | 60.8% | 98.5% | 106.1% | 173.5% | -95.3% | 1,938.0% | -72.1% | -80.1% | -30.3% | -91.7% | 67.9% | -27.7% | 4.8% | 10.5% | 39.3% | 23.5% | -9.7% | -25.0% | 17.3% | 20.9% | 206.8% | 126.3% | 12.0% | -36.9% | 60.8% | 366.2% | -157.4% | -12.2% | -91.6% | -110.7% | 23.6% | 122.2% | 95.2% | -46.9% | 101.0% | 81.9% | |
| 0.7% | 27.1% | 3.8% | 8.0% | 10.9% | 74.7% | 17.9% | 24.9% | 26.0% | -24.0% | 405.6% | -14.4% | -18.6% | -3.0% | -18.9% | 14.6% | -11.7% | -3.4% | -22.4% | 3.0% | 2.4% | -2.2% | 10.4% | -7.9% | 4.6% | 167.4% | 27.1% | 3.3% | -5.7% | -3.9% | 88.2% | -32.5% | 1.6% | -18.9% | -17.0% | 13.4% | 20.7% | 20.1% | -21.1% | 24.8% | 14.0% | |
| 3.0% | -8.2% | 17.4% | 21.6% | 25.2% | -13.9% | 80.6% | 81.3% | 147.5% | -71.3% | 1,532.4% | -57.7% | -61.5% | -27.3% | -72.8% | 53.3% | -16.0% | 8.2% | 32.8% | 36.3% | 21.2% | -7.5% | -42.1% | -1.8% | 0.7% | -64.7% | 95.4% | 8.7% | -31.3% | 64.7% | 278.1% | -125.0% | -13.8% | -72.6% | -93.6% | 10.2% | 101.6% | 75.1% | -25.8% | 76.2% | 67.9% | |
| 38.9% | 58.5% | 45.1% | 55.7% | 52.7% | 64.4% | 109.0% | 124.8% | 210.6% | -55.7% | 46.0% | -8.6% | -9.4% | 84.0% | -46.7% | 93.1% | -1.9% | 32.3% | 44.8% | 28.3% | 37.8% | 14.3% | 14.5% | 44.3% | 44.2% | 248.9% | 148.6% | 49.1% | -10.7% | 93.1% | 395.0% | -133.1% | 6.6% | -69.3% | -89.4% | 43.9% | 129.2% | 111.3% | -27.6% | 113.7% | 94.2% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.